60 Participants Needed

Surgical Techniques for Rotator Cuff Tears

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Nova Scotia Health Authority
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores two surgical techniques to repair massive rotator cuff tears in the shoulder. It seeks to determine which method—bridging reconstruction using a human dermal implant or lower trapezius tendon transfer—better maintains shoulder space, improves strength, and enhances quality of life. Participants will be randomly assigned to one of these surgeries and monitored for at least two years. Ideal candidates are adults with an MRI-confirmed large rotator cuff tear involving two tendons and measuring over 5 cm, without significant muscle loss or certain other health conditions.

As an unphased trial, this study allows patients to contribute to valuable research that could improve future treatment options.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these surgical techniques are safe for treating rotator cuff tears?

Research shows that both surgical techniques in this trial—lower trapezius tendon transfer and bridging reconstruction—are safe options for treating large, irreparable rotator cuff tears.

For the lower trapezius tendon transfer, studies indicate it effectively reduces pain and improves shoulder movement. Patients generally tolerate it well, with no major safety concerns reported.

The bridging reconstruction method uses donated tissue to repair the rotator cuff. Research has found this method helps maintain the repair more often, reducing the chance of failure. It also tends to preserve muscle better, benefiting long-term shoulder function. Patients have reported better outcomes without significant safety issues.

In summary, previous studies have shown both techniques to be generally safe and well-tolerated, with no major safety concerns for either option.12345

Why are researchers excited about this trial?

Researchers are excited about these surgical techniques for rotator cuff tears because they offer innovative approaches to repair severe shoulder injuries. The Bridging Reconstruction Repair uses a human dermal allograft, which acts like a scaffold, to bridge and anchor the torn rotator cuff—this is a novel use of biological material to enhance healing and strength. The Lower Trapezius Tendon Transfer involves moving a tendon from the back to the shoulder, utilizing the body's own tissue to restore function and stability, which could improve outcomes compared to traditional repair methods. Both techniques aim to provide more durable and effective solutions for massive rotator cuff tears, potentially reducing the risk of re-injury and enhancing shoulder mobility.

What evidence suggests that these surgical techniques are effective for rotator cuff tears?

This trial will compare two surgical techniques for treating rotator cuff tears. Research has shown that lower trapezius tendon transfer (LTT), one of the techniques studied in this trial, can improve shoulder movement and reduce pain for people with large rotator cuff tears. Studies have found significant improvements in both clinical and functional outcomes after this procedure.

Similarly, bridging reconstruction repair (BRR), the other technique under study, uses a human dermal allograft (a type of tissue implant) and also shows promising results. Research indicates that BRR lowers the risk of structural failure and helps maintain muscle mass better than some other methods. Long-term studies suggest that BRR leads to good outcomes with low rates of further rotator cuff issues over five years. Both techniques offer promising options for people with severe rotator cuff tears.12678

Are You a Good Fit for This Trial?

This trial is for adults over 18 with a confirmed MRI diagnosis of massive rotator cuff tears larger than 5cm, involving two tendons and considered irreparable. Candidates should have less than 50% muscle atrophy. It's not specified who can't join.

Inclusion Criteria

I have a tear in two tendons that cannot be repaired.
<50% muscle atrophy
Tear size >5cm
See 1 more

Exclusion Criteria

Pregnancy
I have stiffness and limited movement in my shoulder.
I have paralysis in my shoulder.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Pre-operative

Routine radiographs and MRI are obtained; informed consent process

1 week
1 visit (in-person)

Surgical Treatment

Participants undergo either bridging reconstruction or lower trapezius tendon transfer

1 day
1 visit (in-person)

Postoperative Recovery

Shoulder immobilized in a sling; passive motion allowed; progression to active motion and strengthening

12 weeks
Follow-up at 2 weeks, 6 weeks, 3 months

Follow-up

Participants are monitored for safety and effectiveness; clinical examinations and questionnaires

24 months
Visits at 6 months, 12 months, 24 months

What Are the Treatments Tested in This Trial?

Interventions

  • Bridging Reconstruction
  • Lower Trapezius Transfer
Trial Overview The study compares two surgical methods for repairing large to massive rotator cuff tears: bridging reconstruction using an acellular human dermal allograft implant versus arthroscopic assisted lower trapezius tendon transfer, assessing their impact on shoulder distance maintenance, strength, motion range, and quality of life.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Lower Trapezius Tendon TransferActive Control1 Intervention
Group II: Bridging Reconstruction RepairActive Control1 Intervention

Bridging Reconstruction is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Bridging Reconstruction for:
🇪🇺
Approved in European Union as Bridging Reconstruction for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nova Scotia Health Authority

Lead Sponsor

Trials
302
Recruited
95,300+

Published Research Related to This Trial

The lower trapezius tendon transfer has become a popular surgical option for treating irreparable posterosuperior rotator cuff tears, showing promising results in improving shoulder function, particularly external rotation.
Various surgical techniques for the LT tendon transfer, including open, mini-open, and arthroscopic-assisted methods, provide flexibility in treatment approaches based on patient needs and surgeon preference.
Techniques for lower trapezius tendon transfer for the management of irreparable posterosuperior rotator cuff tears.Ghoraishian, M., Stone, MA., Elhassan, B., et al.[2021]
Physiologically tensioned lower trapezius transfer (LTT) significantly improved shoulder movement and reduced the upward migration of the humeral head compared to both undertensioned and overtensioned LTT, indicating that proper tensioning is crucial for effective surgical outcomes.
While LTT improved shoulder kinematics after an irreparable rotator cuff tear, it did not fully restore the shoulder's native function, suggesting that while tensioning is important, other factors may also influence recovery.
Physiological Tensioning During Lower Trapezius Transfer for Irreparable Posterosuperior Rotator Cuff Tears May Be Important for Improvement in Shoulder Kinematics.Muench, LN., Rupp, MC., Obopilwe, E., et al.[2023]
In a study of 16 patients with massive irreparable rotator cuff tears, simultaneous lower trapezius tendon transfer and interpositional repair led to significant improvements in shoulder function, including increased forward flexion, abduction, and external rotation after an average follow-up of 29 months.
The combination of these surgical techniques resulted in improved pain scores and overall shoulder function, as measured by UCLA and Constant-Murley scores, without a significant increase in complications, indicating a safe and effective treatment option.
The clinical results of lower trapezius tendon transfer with the peroneus longus allograft augmentation combined with interpositional repair with fascia lata in massive irreparable rotator cuff tears.Bozoğlan, M., Danışman, M., Demir, T., et al.[2023]

Citations

Bridging Reconstruction With Interpositional Dermal ...BRR results in a significantly reduced structural failure rate and a trend toward better preservation of supraspinatus muscle mass compared with maximal repair.
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38986852/
Bridging Reconstruction With Interpositional Dermal ...BRR results in a significantly reduced structural failure rate and a trend toward better preservation of supraspinatus muscle mass compared with maximal repair.
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40089011/
Bridging reconstruction for massive rotator cuff tears has a ...The results of this study show that BRR with dermal allograft has promising results over a 5-year follow-up with low progression to rotator ...
Bridging reconstruction for massive rotator cuff tears has a ...The results of this study show that BRR with dermal allograft has promising results over a 5-year follow-up with low progression to rotator cuff arthropathy and ...
Bridging Reconstruction for Massive Rotator Cuff Tears has ...The results of this study show that bridging reconstruction with dermal allograft has promising results over a 5-year follow-up with low ...
Interposition Graft Bridging Reconstruction of Irreparable ...A retrospective chart review was conducted for all patients who underwent bridging reconstruction between 2010 and 2018.
Bridging Reconstruction Using a Biocomposite Scaffold for ...This technical video shows arthroscopic rotator cuff repair with bridging reconstruction using the BioBrace (Biorez) graft in the right shoulder ...
Bridging Allograft Reconstruction Is Superior to Maximal ...Rotator cuff bridging reconstruction using a dermal allograft demonstrated improved patient-reported outcomes as measured using the WORC index 2 years ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security